Medicine for inflammatory bowel disease may protect against severe COVID-19 https://t.co/h9GSA7m4Mw https://t.co/ILoGrcCmiu https://t.co/JosQV02K7l https://t.co/0aJAWcWc52
RT @LindaTutty: T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy #IBD https://t.…
T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy #IBD https://t.co/r6DAinMFfQ
Following on from the excellent data generated by the Clarity-IBD Study and the VIP Study in the U.K. here is cellular immunity T-cell responses data to SARS-CoV-2 to reassure your IBD patients.@CrohnsColitisUK @GutsCharityUK 👇
T-cell and antibody responses to COVID vaccination in IBD are poorly correlated. While anti-TNF therapy blunts the antibody response to COVID vaccination, cellular immunity is augmented by anti-TNFs. A message 📨to tell to patients and reassure them!! http
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
RT @medical_xpress: Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https:…
Medicine for #inflammatoryboweldisease may protect against severe #COVID-19 @frontiersin https://t.co/ELN7WVCxb3 https://t.co/Bbmp4cUXkM
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
RT @IBDJournals: From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/2…
From @IBDCedarsSinai - in 303 patients with #IBD who received the SARS-CoV2 💉, T cell response was preserved w anti-IL12/23s & anti-integrins & increased w/ anti-TNFs. This may explain the noted ⬇️in #COVID hospitalization or death in pts on anti-T
New article: The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy https://t.co/d3Ec81lf6P #kidneycancer #oncology https://t.co/CNByltmPJ7